Article · 30 Jun 2026
Review articlePublished 2016
Proteomics: An Indispensable Tool for Novel Biomarker Identification in Melanoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Melanoma is a prevalent disease with a high mortality rate. The advent of proteomics has enabled the identification of various prognostic and diagnostic melanoma biomarkers, fulfilling a vital need. The development of various protein fractionation and analysis tools has advanced the role of proteomics in analyzing complex protein samples obtained from melanoma patients. Proteomics is also being utilized to help guide drug design and the development of treatment algorithms. Ultimately, proteomics-based methodologies have proven to be paramount to the success of research being done on melanoma and the drugs used for treatment. These techniques will continue to shed light on the mechanisms of action driving therapeutic efficacy and toxicity, in hopes of extending survival and improving patient outcomes and quality of life.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Data Mining in Genomics & Proteomics.
Article · 30 Jun 2026
Comparative Genomics: Revealing Evolutionary Patterns Across Biological Worlds
Article · 30 Jun 2026
Predicting the Hidden Roles of Proteins through Computational Function Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Data Mining in Genomics & Proteomics
- SubjectBiochemistry & Biotechnology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Payal Mittal”
- BylineArticles whose byline prints “Manish Jain”
